11-20 of 505
Post: The Parker Institute for Cancer Immunotherapy Partners with Xyphos Biosciences to Develop Universal Programmable CAR-T Cells for Cancer Treatment
SAN FRANCISCO and SOUTH SAN FRANCISCO, Calif. – The Parker Institute for Cancer Immunotherapy and Xyphos Biosciences today announced a collaboration to...
Post: A Nobel Prize for Jim Allison and Tasuku Honjo: A Win for Cancer Research
The 2018 Nobel Prize in Physiology or Medicine was awarded today to James P. Allison and Tasuku Honjo for groundbreaking discoveries that have...
Post: Nobel Prize for Medicine Goes to Cancer Immune Therapy Pioneers
Immunologists James P. Allison and Tasuku Honjo have won this year’s Nobel Prize in Physiology or Medicine for their pioneering work...
Post: Cancer R&D stars Jim Allison, Tasuku Honjo awarded Nobel prize for immunotherapy discoveries
Immunotherapy pioneers James Allison and Tasuku Honjo has jointly won the 2018 Nobel prize in physiology and medicine “for their discovery...
Post: James Allison, Parker Institute for Cancer Immunotherapy Director, Wins 2018 Nobel Prize in Medicine or Physiology for Research on Immune Checkpoint Inhibitors
Allison shares medicine’s top prize for uncovering keys to regulating immune system, leading to major advancements in cancer treatment James Allison,...
Post: Parker Institute Researchers Featured at Fourth International Immunotherapy Conference 2018 in New York #CICON18
Parker Institute for Cancer Immunotherapy investigators will present the latest findings in immuno-oncology research at the Fourth International Cancer lmmunotherapy Conference...